APA (2000). Diagnostic and Statistical Manual of Mental Disorders, 4th edn, text revision (DSM-IV-TR). American Psychiatric Association: Washington, DC.
Barry, ES, Naus, MJ, Rehm, LP (2004). Depression and implicit memory: understanding mood congruent memory bias. Cognitive Therapy and Research 28, 387–414.
Beck, AT, Rush, AJ, Shaw, BF, Emery, G (1979). Cognitive Therapy of Depression. Guilford Press: New York.
Beck, AT, Ward, CH, Mendelson, M, Mock, JE, Erbaugh, JK (1961). An inventory for measuring depression. Archives of General Psychiatry 4, 561–571.
Bothwell, S, Weissman, MM (1977). Social impairments four years after an acute depressive episode. American Journal of Orthopsychiatry 47, 231–237.
Cassano, P, Fava, M (2002). Depression and public health: an overview. Journal of Psychosomatic Research 53, 849–857.
Crowe, M, Luty, S (2005). The process of change in Interpersonal Psychotherapy (IPT) for depression: a case study for the new IPT therapist. Psychiatry: Interpersonal and Biological Processes 68, 43–54.
De Lisio, G, Maremmani, I, Perugi, G, Cassano, GB, Deltito, J, Akiskal, HS (1986). Impairment of work and leisure in depressed outpatients. A preliminary communication. Journal of Affective Disorders 10, 79–84.
Dimidjian, S, Hollon, SD, Dobson, KS, Schmaling, KB, Kohlenberg, RJ, Addis, ME, Gallop, R, McGlinchey, JB, Markley, DK, Gollan, JK, Atkins, DC, Dunner, DL, Jacobson, NS (2006). Randomized trial of behavioral activation, cognitive therapy, and antidepressant medication in the acute treatment of adults with major depression. Journal of Consulting and Clinical Psychology 74, 658–670.
Dunn, TW, Jarrett, RB (2009). Psychosocial functioning. In The International Encyclopedia of Depression (ed. Ingram, R.), pp. 468–471. Springer: New York, NY.
Elkin, I, Shea, TM, Watkins, JT, Imber, SD, Sotsky, SM, Collins, JF, Glass, DR, Pilkonis, PA, Leber, WR, Docherty, JP, Fiester, SJ, Parloff, MB (1989). National Institute of Mental Health Treatment of Depression Collaborative Research Program: general effectiveness of treatments. Archives of General Psychiatry 46, 802–-982.
Evans, MD, Hollon, SD, DeRubeis, RJ, Piasecki, JM, Grove, WM, Garvey, MJ, Tuason, VB (1992). Differential relapse following cognitive therapy and pharmacotherapy for depression. Archives of General Psychiatry 49, 802–808.
Finkelstein, SN, Berndt, ER, Greenberg, PE, Parsley, RA, Russell, JM, Keller, MB (1996). Improvement in subjective work performance after treatment of chronic depression: some preliminary results. Psychopharmacology Bulletin 32, 33–40.
First, MB, Spitzer, RL, Gibbon, M, Williams, JB (1996). Structured Clinical Interview for DSM-IV Axis I Disorders – Patient Edition (SCID-I/P, Version 2.0). Biometrics Research Department, New York State Psychiatric Institute: New York, NY.
Follette, WC, Greenberg, LS (2005). Technique factors in treating dysphoric disorders. In Principles of Therapeutic Change that Work (ed. Castonguay, L. G. and Beutler, L. E.), pp. 83–110. Oxford University Press: New York.
Garratt, G, Ingram, RE, Rand, KL, Sawalani, G (2007). Cognitive processes in cognitive therapy: evaluation of the mechanisms of change in the treatment of depression. Clinical Psychology: Science and Practice 14, 224–239.
Gorenstein, C, Andrade, L, Moreno, RA, Artes, R (2002). Social adjustment in depressed patients treated with venlafaxine and amitriptyline. International Clinical Psychopharmacology 17, 171–175.
Greenberg, PE, Kessler, RC, Birnbaum, HG, Leong, SA, Lowe, SW, Berglund, PA, Corey-Lisle, PK (2003). The economic burden of depression in the United States: how did it change between 1990 and 2000? Journal of Clinical Psychiatry 64, 1465–1475.
Hamilton, M (1960). A rating scale for depression. Journal of Neurology, Neurosurgery and Psychiatry 12, 52–62.
Hays, RD, Wells, KB, Sherbourne, CD, Rogers, W, Spritzer, K (1995). Functioning and well-being outcomes of patients with depression compared with chronic general medical illnesses. Archives of General Psychiatry 52, 11–19.
Hirschfeld, RM, Dunner, DL, Keitner, G, Klein, DN, Koran, LM, Kornstein, SG, Markowitz, JC, Miller, I, Nemeroff, CB, Ninan, PT, Rush, AJ, Schatzberg, AF, Thase, ME, Trivedi, MH, Borian, FE, Crits-Christoph, P, Keller, MB (2002). Does psychosocial functioning improve independent of depressive symptoms? A comparison of nefazodone, psychotherapy, and their combination. Biological Psychiatry 51, 123–133.
Hirschfeld, RM, Russell, JM, Delgado, PL, Fawcett, J, Friedman, RA, Harrison, WM, Koran, LM, Miller, IW, Thase, ME, Howland, RH, Connolly, MA, Miceli, RJ (1998). Predictors of response to acute treatment of chronic and double depression with sertraline or imipramine. Journal of Clinical Psychiatry 59, 669–675.
Hollon, SD, DeRubeis, RJ, Evans, MD, Wiemer, MJ, Garvey, MJ, Grove, WM, Tuason, VB (1992). Cognitive therapy and pharmacotherapy for depression: singly and in combination. Archives of General Psychiatry 49, 774–781.
Hollon, SD, DeRubeis, RJ, Shelton, RC, Amsterdam, JD, Salomon, RM, O'Reardon, JP, Lovett, ML, Young, PR, Haman, KL, Freeman, BB, Gallop, R (2005). Prevention of relapse following cognitive therapy vs. medications in moderate to severe depression. Archives of General Psychiatry 62, 417–422.
Jarrett, RB, Thase, ME (2010). Comparative efficacy and durability of continuation phase cognitive therapy for preventing recurrent depression: design of a double-blinded fluoxetine- and pill placebo-controlled randomized trial with 2-year follow-up. Contemporary Clinical Trials 31, 355–377.
Keller, MB (2003). Past, present, and future directions for defining optimal treatment outcome in depression: remission and beyond. Journal of the American Medical Association 289, 3152–3160.
Keller, MB, Lavori, PW, Friedman, B, Nielsen, E, Endicott, J, McDonald-Scott, P, Andreasen, NC (1987). The longitudinal interval follow-up evaluation: a comprehensive method for assessing outcome in prospective longitudinal studies. Archives of General Psychiatry 44, 540–548.
Kessler, RC, Berglund, P, Demler, O, Jin, R, Walters, EE (2005). Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Archives of General Psychiatry 62, 593–602.
Kline, RB (2005). Principles and Practice of Structural Equation Modeling. Guilford Press: New York.
Kraemer, HC, Stice, E, Kazdin, A, Offord, D, Kupfer, D (2001). How do risk factors work together? Mediators, moderators, independent, overlapping, and proxy risk factors. American Journal of Psychiatry 158, 848–856.
Lenderking, WR, Tennen, H, Nackley, JF, Hale, MS, Turner, RR, Testa, MA (1999). The effects of venlafaxine on social activity level in depressed outpatients. Journal of Clinical Psychiatry 60, 157–163.
Leon, AC, Solomon, DA, Mueller, TI, Turvey, CL, Endicott, J, Keller, MB (1999). The Range of Impairment Functioning Tool (LIFE-RIFT): a brief measure of functional impairment. Psychological Medicine 29, 869–878.
Miller, IW, Keitner, GI, Schatzberg, AF, Klein, DN, Thase, ME, Rush, AJ, Markowitz, JC, Schlager, DS, Kornstein, SG, Davis, SM, Harrison, WM, Keller, MB (1998). The treatment of chronic depression, part 3: Psychosocial functioning before and after treatment with sertraline or imipramine. Journal of Clinical Psychiatry 59, 608–619.
Mintz, J, Mintz, LI, Arruda, MJ, Hwang, SS (1992). Treatments of depression and the functional capacity to work. Archives of General Psychiatry 49, 761–768.
Moos, RH, Cronkite, RC (1999). Symptom-based predictors of a 10-year chronic course of treated depression. Journal of Nervous and Mental Disease 187, 360–368.
Ro, E, Clark, LA (2009). Psychosocial functioning in the context of diagnosis: assessment and theoretical issues. Psychological Assessment 21, 313–324.
Rush, AJ, Gullion, CM, Basco, MR, Jarrett, RB, Trivedi, MH (1996). The Inventory of Depressive Symptomatology (IDS): psychometric properties. Psychological Medicine 26, 477–486.
Rush, AJ, Kraemer, HC, Sackeim, HA, Fava, M, Trivedi, MH, Frank, E, Ninan, PT, Thase, ME, Gelenberg, AJ, Kupfer, DJ, Regier, DA, Rosenbaum, JF, Ray, O, Schatzberg, AF; ACNP Task Force (2006). Report by the ACNP task force on response and remission in major depressive disorder. Neuropsychopharmacology 31, 1841–1853.
Schafer, J, Graham, J (2002). Missing data: our view of the state of the art. Psychological Methods 7, 147–177.
Spanier, GB (1976). Measuring dyadic adjustment: new scales for assessing the quality of marriage and similar dyads. Journal of Marriage and the Family 38, 15–28.
Thase, ME (2003). Evaluating antidepressant therapies: remission as the optimal outcome. Journal of Clinical Psychiatry 64 (Suppl. 13), 18–25.
Vittengl, JR, Clark, LA, Jarrett, RB (2004). Improvement in social-interpersonal functioning after cognitive therapy for recurrent depression. Psychological Medicine 34, 643–658.
Vittengl, JR, Clark, LA, Jarrett, RB (2009). Deterioration in psychosocial functioning predicts relapse/recurrence after cognitive therapy for depression. Journal of Affective Disorders 112, 139–143.
Weissman, MM, Bothwell, S (1976). Assessment of social adjustment by patient self-report. Archives of General Psychiatry 33, 1111–1115.
Weissman, MM, Markowitz, JC, Klerman, GL (2000). Comprehensive Guide to Interpersonal Psychotherapy. Basic Books: New York.
Weissman, MM, Olfson, M, Gameroff, MJ, Feder, A, Fuentes, M (2001). A comparison of three scales for assessing social functioning in primary care. American Journal of Psychiatry 158, 460–466.
Whisman, MA (1993). Mediators and moderators of change in cognitive therapy of depression. Psychological Bulletin 114, 248–265.
Wilson, G, Fairburn, CC, Agras, W, Walsh, B, Kraemer, H (2002). Cognitive-behavioral therapy for bulimia nervosa: time course and mechanisms of change. Journal of Consulting and Clinical Psychology 70, 267–274.
Young, J, Beck, AT (1980). Cognitive Therapy Scale: Rating Manual. Center for Cognitive Therapy: Philadelphia.